---
schema_version: "secwatch.filing_event.v1"
accession: "0001171520-26-000225"
form_type: "8-K"
ticker: "CTTH"
cik: "0001035422"
company_name: "CTT PHARMACEUTICAL HOLDINGS, INC."
filed_at: "2026-08-12T11:30:23+00:00"
generated_at: "2026-08-12T11:35:13.770483+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CTT Pharma gets U.S. patent for nicotine, vitamin, caffeine delivery tech

## Summary
- USPTO approved continuation-in-part patent for micelle delivery technology, effective Aug 11, 2026.
- Patent covers nicotine, vitamins, and caffeine; enables dissolvable strips, gum, pouches, lozenges, and dissolving tablets.
- Company states it will continue strengthening its patent portfolio.

## SEC filing metadata
- accession: 0001171520-26-000225
- form_type: 8-K
- ticker: CTTH
- cik: 0001035422
- company_name: CTT PHARMACEUTICAL HOLDINGS, INC.
- filed_at: 2026-08-12T11:30:23+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/0001171520-26-000225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/eps12766_ctth.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171520-26-000225
- JSON: https://secwatch.observer/filing/0001171520-26-000225.json
- Plain text: https://secwatch.observer/filing/0001171520-26-000225.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.